Paull Robert Bradley
Insider CIK 1711254 · KALA Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2021-06-17 | 2021-06-21 | 20,000 | — | $0 | 40,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2020-06-25 | 2020-06-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | J Other | 2020-03-11 | 2020-06-29 | 1,287 | — | $0 | 2,361 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2019-06-05 | 2019-06-07 | 21,000 | — | $0 | 21,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2018-06-12 | 2018-06-14 | 12,960 | — | $0 | 12,960 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | J Other | 2018-06-11 | 2020-06-29 | 477 | — | $0 | 1,074 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | J Other | 2018-05-18 | 2020-06-29 | 597 | — | $0 | 597 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion deriv | 2017-07-25 | 2017-07-26 | 900,146 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion deriv | 2017-07-25 | 2017-07-26 | 16,152 | — | $0 | 16,152 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion deriv | 2017-07-25 | 2017-07-26 | 84,130 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion deriv | 2017-07-25 | 2017-07-26 | 3,677,373 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion deriv | 2017-07-25 | 2017-07-26 | 1,666,666 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion deriv | 2017-07-25 | 2017-07-26 | 31,494 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion | 2017-07-25 | 2017-07-26 | 1,204,937 | — | $0 | 1,204,937 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2017-07-19 | 2017-07-21 | 12,960 | — | $0 | 12,960 | SEC↗ |